Afuco™ Anti-Human SFRP4 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-SFRP4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-SFRP-4 antibodies are used for treating or preventing a secreted frizzled related polypeptide type 4-associated disorder. The disorder may be cancers; apoptosis resulting from ischemia, heart failure; myocardial infarction; stroke; neurodegenerative disorder; Huntington's Disease; peripheral demyelinating disease; Multiple Sclerosis; Alzheimer's Disease; Amyotrophic Lateral Sclerosis; Parkinson's Disease; trauma; coronary heart disease; inflammation; or inflammatory bowel disease.
Supplier Creative Biolabs
Product # AFC-542CL
Pricing Inquiry
Host Humanized
Target SFRP4
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C. Avoid multiple freeze/thaw cycles.
Feedback